Over the past decade, tremendous strides have been made in the treatment of adult lymphomas -- a group of blood cancers that begins in the white blood cells that fight infection in the body. Personalized and targeted therapies are resulting in higher success rates and patients living longer. Ongoing progress continues to offer hope and healing for patients facing this disease.
At the Frontier of Lymphoma Care
Top Diagnostic Expertise
Nationally Designated Cancer Center
Blood and Bone Marrow Stem Cell Transplantation
Individualized Treatment by a Multidisciplinary Team
Specialized Care for Adolescents and Young Adults
A Legacy in Lymphoma Care
The University of Chicago Medicine has been at the forefront of this great move forward in lymphoma care. Here, the brightest minds in medicine work every day to advance the care of patients with lymphoma. Our lymphoma experts are committed to developing new therapies for this complex disease and to bringing the latest treatments to our patients as quickly as possible. One of the busiest lymphoma programs in Chicago, we manage care for thousands of patients and see approximately 250 new cases each year.
Our hematopathologists (physician-scientists who analyze blood samples and tissue to identify lymphoma) have extensive knowledge and expertise in accurately pinpointing the different subtypes of lymphoma -- some of which are particularly difficult to diagnose. Physicians from around the nation and the world regularly consult with our hematopathologists on complicated lymphoma cases.
We also use the newest technology for diagnosing and staging lymphoma, including a combination PET-CT scanner.
Our lymphoma specialists are members of the University of Chicago Comprehensive Cancer Center (UCCCC), one of only two National Cancer Institute-designated Comprehensive Cancer Centers in Illinois. Here, teams of physicians and scientists work across disciplines to discover new methods for detecting and treating cancer through laboratory studies, prevention research and clinical trials.
»Learn more about lymphoma research and clinical trials.
We take an aggressive approach to treating lymphomas that return after initial treatment. In some cases, blood and bone marrow stem cell transplant offers the best chance of cure for patients with relapsed lymphoma. »Learn more about blood and bone marrow stem cell transplantation.
Each patent’s care is directed and managed by physicians and nurses dedicated to the treatment of lymphoma. At the same time, patients benefit from the knowledge and expertise of many other specialists and researchers at the University of Chicago Medicine. Here, a group of experts meets weekly to discuss each patient’s case and to design individualized care plans. The multidisciplinary lymphoma team consists of:
- Hematologists/oncologists who specialize in lymphoma care
- Radiation oncologists
- Infectious disease specialists
- Social workers
Lymphomas (Hodgkin and non-Hodgkin) are the third most common cancer in adolescents and young adults. The Adolescent and Young Adult (AYA) Oncology Program at the University of Chicago Medicine addresses the unique personal, psychosocial and medical needs of this age group. »Read more about our AYA program.
We offer long-term follow-up and care for adults who were treated for lymphoma as adolescents or young adults. Patients receive an individualized survivorship plan to help them address any medical or psychosocial issues they experience as a result of cancer or its treatment.
More than 40 years ago, University of Chicago physician John E. Ultmann, MD, and his colleagues were instrumental in defining an approach to the diagnosis, staging and treatment of lymphomas that still guides lymphoma care today.
Today, our lymphoma specialists carry on Dr. Ultmann’s legacy -- in their ongoing research and in their dedication to understanding and sharing their knowledge of the disease. Each year, specialists from around the world gather at the International Ultmann Chicago Lymphoma Symposium -- co-sponsored by the University of Chicago Medicine Comprehensive Cancer Center and dedicated to the science and clinical care of lymphoma.